Services DMPK In Vitro ADME
In Vitro ADME Services
Comprehensive in vitro ADME studies that help teams evaluate metabolism, permeability, distribution, and drug interaction potential early in the drug discovery process.
From physicochemical characterization and metabolic stability testing to transporter studies and metabolite identification, BioDuro generates the data needed to identify potential liabilities, optimize compounds, and support confident candidate selection across small molecules, peptides, PROTACs, ADCs, and oligonucleotide therapeutics.
In Vitro ADME Support for Discovery Programs
BioDuro provides in vitro ADME services designed to help researchers better understand compound disposition, identify potential liabilities earlier, and support candidate selection during discovery and preclinical development.
Metabolism & Stability Assessment
In vitro assays supporting evaluation of metabolic stability, intrinsic clearance, and compound behavior across biological systems.
- Liver microsome stability assays
- Hepatocyte stability studies
- Plasma stability evaluation
- Intrinsic clearance assessment
Drug Interaction Evaluation
Capabilities supporting assessment of drug-drug interaction risk and transporter-related liabilities during discovery.
- CYP450 inhibition studies
- CYP induction assays
- Transporter interaction studies
Discovery-Focused Decision Support
ADME data helping teams prioritize compounds, improve exposure profiles, and guide medicinal chemistry optimization.
- Early liability identification
- Structure–property relationship support
- Candidate selection guidance
In Vitro ADME Capabilities
Accelerate candidate selection with in vitro ADME services that provide critical insights into metabolism, permeability, protein binding, and compound disposition during drug discovery.
Metabolic Stability Studies
Microsomal, hepatocyte, and plasma stability studies.
CYP450 Inhibition & Induction
Assessment of cytochrome P450 interaction potential.
Plasma Protein Binding
Evaluation of compound binding and free fraction.
Transporter Interaction Studies
Assessment of uptake and efflux transporter interactions.
In vitro ADME studies evaluate absorption, distribution, metabolism, and excretion properties to help researchers better understand compound behavior during drug discovery.
BioDuro provides metabolic stability studies, CYP450 inhibition and induction assays, plasma protein binding, transporter interaction studies, and metabolite profiling workflows.
These studies help identify potential liabilities, evaluate pharmacokinetic properties, and support compound optimization before advancing into in vivo development studies.
Yes. BioDuro supports small molecules, peptides, ADCs, oligonucleotides, and other complex therapeutic modalities through fit-for-purpose ADME workflows.
Typical turnaround times for many in vitro ADME studies are approximately 5 working days. Certain assays may require additional time, including cell-based assays, metabolite identification, uptake transporter studies, whole blood assays, and CYP450 induction studies depending on study complexity and scope.
Download the In Vitro ADME Overview
Explore BioDuro’s in vitro ADME capabilities supporting metabolism, stability, transporter interaction, and pharmacokinetic evaluation across discovery programs.
DMPK & ADME Services
BioDuro provides in vitro ADME, bioanalysis, pharmacokinetics, and exploratory toxicology expertise to help teams evaluate compound behavior, identify liabilities earlier, and guide candidate optimization.